A Study of Abatacept in Patients With Active Crohn's Disease

NCT00406653 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

451

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Crohn's Disease

Interventions

DRUG: abatacept
DRUG: placebo
DRUG: abatacept

Sponsor

Bristol-Myers Squibb